Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Atrophic Dry Age Related Macular Degeneration

NCT03392324 is registered in ClinicalTrials.gov with Science Corporation as lead sponsor.

NCT NCT03392324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Atrophic Dry Age Related Macular Degeneration
Lead sponsor
Science Corporation
Phase
Not applicable
Overall status
Completed
Start date
April 26, 2018
Completion date
May 20, 2026
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry age-related macular degeneration